Opinion
Video
Intravascular and Extravascular Hemolysis MoA in PNH
Medical experts illustrate the nature of hemolysis in PNH and characteristics unique to the disease state.
EP: 1.PNH Overview and Pathophysiology
Now Viewing
EP: 2.Intravascular and Extravascular Hemolysis MoA in PNH
EP: 3.Utilizing Health Information Technology to Bridge Gaps in PNH Treatment Programming
EP: 4.Key Treatment Considerations for Patients Diagnosed With PNH
EP: 5.Complement System Role in PNH Treatment Approach
EP: 6.Eculizumab Impact on PNH Treatment Landscape and Unmet Needs in PNH Management
EP: 7.Efficacy End Points For PNH Treatment
EP: 8.Efficacy and Safety Trials Results of Complement Inhibitors
EP: 9.Treatment Adherence and Cost Considerations Surrounding Various Routes of PNH Treatment Administration
EP: 10.Investigational Therapies Paving New PNH Treatment Pathways
EP: 11.Key Financial Factors Associated With Typical PNH Treatment Journey
EP: 12.Navigating Transfusion Requirements in PNH Treatment
EP: 13.Considerations for Managing PNH Treatment Complications
EP: 14.Infection Risk Management Counseling For Patients Receiving Treatment for PNH
EP: 15.Ensuring PNH Treatment Access and Adherence to Therapies
EP: 16.Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway
Video content above is prompted by the following:
- Please describe the mechanisms of intravascular and extravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH).
- What distinguishes PNH from other hematological disorders in terms of its clinical manifestations, particularly focusing on hemolysis, thrombosis, and bone marrow failure?
Related Videos
Related Content
